Mutations in the gene encoding the Krebs cycle enzyme fumarate hydratase (FH) predispose to hereditary leiomyomatosis and renal cell cancer in affected individuals. FH-associated neoplasia is characterized by defective mitochondrial function and by upregulation of transcriptional pathways mediated by hypoxiainducible factor (HIF), although whether and by what means these processes are linked has been disputed. We analysed the HIF pathway in Fh12/2 mouse embryonic fibroblasts (MEFs), in FH-defective neoplastic tissues and in Fh12/2 MEFs re-expressing either wild-type or an extra-mitochondrial restricted form of FH. These experiments demonstrated that upregulation of HIF-1a occurs as a direct consequence of FH inactivation. Fh12/2 cells accumulated intracellular fumarate and manifested severe impairment of HIF prolyl but not asparaginyl hydroxylation which was corrected by provision of exogenous 2-oxoglutarate (2-OG). Re-expression of the extra-mitochondrial form of FH in Fh12/2 cells was sufficient to reduce intracellular fumarate and to correct dysregulation of the HIF pathway completely, even in cells that remained profoundly defective in mitochondrial energy metabolism. The findings indicate that upregulation of HIF-1a arises from competitive inhibition of the 2-OG-dependent HIF hydroxylases by fumarate and not from disruption of mitochondrial energy metabolism.
INTRODUCTION
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an inherited human cancer syndrome characterized by benign smooth muscle tumours and malignant renal papillary carcinoma (1) . Genetic studies revealed that the syndrome is caused by inactivating mutations of the fumarate hydratase (FH) gene (2) . FH is not a 'traditional' suppressor gene with a recognized function in cell proliferation or survival, but encodes an enzyme that is part of the mitochondrial Krebs cycle, suggesting the operation of novel oncogenic mechanisms.
It has been suggested that activation of hypoxia-inducible factor (HIF) contributes to FH-associated oncogenesis by * To whom correspondence should be addressed. Tel: +44 1865287780; Fax: +44 1865287787; Email: patrick.pollard@well.ox.ac.uk or patrickpollard@aol.com # The Author 2010. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org Human Molecular Genetics, 2010, Vol. 19, No. 19 3844-3851 doi:10.1093/hmg/ddq305 Advance Access published on July 21, 2010 activation of hypoxia pathways that promote tumour growth or associated pro-tumourigenic processes such as angiogenesis (3) . FH-associated human tumours display upregulation of HIF (4 -6) . However, the mechanisms contributing to HIF activation have been disputed. As FH inactivation disrupts oxidative mitochondrial metabolism, it has been postulated that dysregulation of energy metabolism may itself contribute directly or indirectly to activation of HIF (7) . In succinate dehydrogenase-deficient cells, activation of HIF has been associated with enhanced generation of reactive oxygen species (ROS) arising from defective mitochondrial function (8) , and similar mechanisms have been proposed in FH deficiency (9) . Enhanced ROS production arising from increased glucose metabolism has also been proposed to contribute to activation of HIF in FH deficiency (10) . An alternative, but not mutually exclusive, hypothesis proposes that the accumulation of fumarate itself activates HIF by competitive inhibition of the 2-oxoglutarate (2-OG) oxygenases that control the levels and activity of HIF-a sub-units (4, 11, 12) .
In oxygenated cells, prolyl hydroxylation at two sites within an internal HIF-a degradation domain promotes binding to the von Hippel -Lindau E3 ligase complex and proteolysis by the ubiquitin -proteasome pathway, whereas asparaginyl hydroxylation at a C-terminal site reduces transcriptional activity by blocking co-activator recruitment. HIF prolyl hydroxylation is catalysed by three closely related enzymes [prolyl hydroxylase domain (PHD) 1, 2 and 3, also termed EGLN, 2, 1 and 3]. HIF asparaginyl hydroxylation is catalysed by a less closely related 2-OG oxygenase [factor inhibiting HIF (FIH)] (reviewed in 13, 14) . It has been proposed that inhibition by fumarate mimics hypoxia, inhibiting these enzymes and allowing HIF to escape destruction and to activate transcription. This hypothesis is of particular interest because it implies that fumarate accumulation itself is a key step in the oncogenic pathway and might be targeted for therapeutic modulation (15) .
FH is expressed not only in the mitochondrion, but also in the cytosol, where it has been proposed to participate in nucleotide, urea cycle and amino acid metabolic pathways (16, 17) . As the HIF hydroxylases are extra-mitochondrial enzymes, this raises a key question as to whether cytosolic expression of FH would be sufficient to correct the dysregulation of HIF, irrespective of the mitochondrial defect, thus distinguishing between the proposed mechanisms for activation of HIF.
Both mitochondrial and cytosolic forms of FH are encoded by the same transcript. The resulting propeptide is targeted to the mitochondrial membrane via its N-terminal mitochondrial targeting sequence (MTS), where it is then cleaved into two smaller peptides: the peptide encoding the MTS sequence is retained within the mitochondrion and the remaining peptide is released into the cytosol (18, 19) . In this work, we have taken advantage of this property to create stable transfectants re-expressing either wild-type or an extra-mitochondrial, but otherwise identical, form of human FH in Fh1-deficient cells. We demonstrate striking upregulation of the HIF pathway in Fh1-deficient cells and that cytoplasmic re-expression of FH is sufficient to completely correct the observed dysregulation of HIF-1a, irrespective of persisting mitochondrial dysfunction.
RESULTS
To establish a system for the study of Fh1 inactivation, we first isolated mouse embryonic fibroblasts (MEFs) from animals bearing a conditionally inactivated Fh1 allele (20) . Adenoviral expression of Cre recombinase in these cells resulted in complete absence of Fh1 expression (Supplementary Material, Fig. S1 ). Fh1 activity in wild-type, Fh1+/+ MEFs was comparable with that in human skin fibroblasts, but totally absent in Fh12/2 MEFs (Fig. 1A) . To define the metabolic consequences of Fh1 inactivation in these cells, we performed 1 H magnetic resonance spectroscopy (MRS) metabolite analysis and measured oxygen consumption in Fh1+/+ and Fh12/2 MEFs. Striking intracellular fumarate accumulation was observed in Fh12/2 cells (Fig. 1B) ; in keeping with the absence of a specific mechanism for fumarate transport across the plasma membrane, fumarate did not appear in medium extracts (data not shown). Fh12/2 MEFs also manifest increased lactate production resulting in increased cellular levels ( Fig. 1C ) consistent with a shift towards glycolysisdriven metabolism. In line with the decreased Fh1 activity, cellular respiration in Fh12/2 MEFs was suppressed. Using a Clark-type oxygen electrode, basal unstimulated mitochondrial respiration was measured in intact cells and was found to be decreased by 80% in the Fh12/2 MEFs compared with Fh1+/+ MEFs (Fig. 1D) .
To determine whether Hif-1a was directly upregulated by Fh1 inactivation, heterogeneous pools of Fh1-deficient MEFs, and individual Fh12/2 clones derived from these pools, were analysed by immunoblotting. These experiments revealed consistent and striking upregulation of Hif-1a protein levels in all Fh1-defective MEFs [ Fig. 2A (i) and data not shown]. As a first test of the hypothesis that upregulation of Hif-1a might be mediated by competitive inhibition of the 2-OG oxygenases that catalyse HIF hydroxylation, we examined the effects of a cell-permeable esterified derivative of 2-OG (dimethyl-2-OG) that increases 2-OG levels within cells. Exposure of Fh12/2 cells to this treatment resulted in the loss of the accumulated Hif-1a. We next determined the effects on a panel of HIF-target genes: BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (Bnip3), hexokinase 2 (Hk2), hactate dehydrogenase A (Ldha) and Glut1 (Slc2a1) [ Fig. 2A (ii)]. All were strongly upregulated in Fh12/2 cells and downregulated by the addition of dimethyl-2-OG to these cells.
In normal cells, Hif prolyl hydroxylation occurs at two proline sites (Pro402 and Pro577 in mouse Hif-1a), whereas HIF asparaginyl hydroxylation occurs at a single site (Asn813 in mouse Hif-1a) To assess directly whether the effects of Fh1 inactivation were due to actions on the hydroxylation of Hif-1a at any or all of these sites, we determined the hydroxylation status of Hif-1a using hydroxy-residuespecific antibodies (Fig. 2B) . Under normoxic conditions, hydroxylated Hif-1a is targeted by the ubiquitin -proteasome pathway for proteasomal degradation. We demonstrated that Hif-1a in Fh12/2 MEFs treated with the proteasomal inhibitor dimethyl-2-OG to Fh12/2 cells under the same conditions strongly enhanced hydroxylation at these sites, consistent with the reversal of that inhibition. In contrast, detectable asparaginyl hydroxylation was observed even in untreated Fh12/2 cells, although this was also increased by the addition of dimethyl-2-OG, suggesting that it was also partially restricted in Fh12/2 cells. Taken together, these experiments indicate that Hif-1a hydroxylation is inhibited in Fh12/2 cells and suggest that prolyl hydroxylation is more sensitive than asparaginyl hydroxylation. The findings also indicate that despite persistent Hif-1a asparaginyl hydroxylation, the HIF transcriptional system is activated. To test whether dysregulation of Hif-1a hydroxylation also occurs in a similar way in FH-associated neoplasia, we examined hyperplastic renal cystic tissue from Fh12/2 mouse kidneys and human FH-deficient papillary renal carcinoma. Results shown in Figure 2C confirm that, in FH-associated neoplasia, HIF-1a prolyl, but not asparaginyl hydroxylation, is strongly inhibited (for comparison, Von Hippel-Lindau (VHL)-defective material is shown, in which HIF-1a accumulates in a form that is hydroxylated on both prolyl and asparaginyl residues). Taken together, these experiments indicate that profound dysregulation of HIF occurs in FH-associated neoplasia as a direct consequence of FH inactivation. We next sought to define the contribution or otherwise of the mitochondrial defect to this process by comparing the effects of re-expression of either a full-length C-terminal V5-tagged human FH gene (FH-V5) or an identical gene lacking the mitochondrial targeting sequence (FH-V5DMTS) in Fh12/2 cells (Supplementary Material, Fig. S2 ). Following transfection of Fh12/2 MEFs with each gene, multiple independent clones were generated. Immunofluorescence microscopy confirmed the predominant intramitochondrial localization of the transfected FH-V5 gene and the cytoplasmic localization of FH-V5DMTS in all clones (Fig. 3A and data not shown) .
Both FH-V5DMTS and FH-V5 transfections substantially corrected the fumarate accumulation that was observed in Fh12/2 cells, although a low level of fumarate persisted in the FH-V5DMTS transfectants (Fig. 3B) . In contrast, measurements of both substrate-stimulated (glutamate) and uncoupled [carbonylcyanide-p-trifluoromethoxyphenylhydrazone (FCCP)] mitochondrial respiration revealed marked differences between the transfectants. Although the introduction of full-length FH (FH-V5) into Fh12/2 cells restored respiration to wild-type levels, FH-V5DMTS transfectants remained defective in respiration, manifesting oxygen consumption similar to the nonmitochondrial oxygen consumption rate observed after inhibition of mitochondrial ATP synthase using oligomycin (Table 1 ). In keeping with defective mitochondrial respiration, Fh12/2 +FHDMTS transfectants, and the parent Fh12/2 MEFs, were unable to maintain cellular ATP levels when cultured in galactose-as opposed to glucose-containing medium. In contrast, this capacity was restored in full-length FH (FH-V5) transfectants. Taken together, these findings demonstrate that although full restoration of respiration via oxidative phosphorylation in Fh12/2 MEFs requires re-expression of mitochondrial FH, cytoplasmic FH is sufficient to largely ablate fumarate accumulation. Thus we argue that comparative studies of the HIF system in these cells should distinguish the effects of the mitochondrial defect (and consequent glucose addiction) from those of fumarate accumulation. 
3846
Human
Strikingly, both sets of transfectants manifest complete loss of the normoxic Hif-1a accumulation that was observed in untransfected Fh12/2 cells. To confirm the effects on the hydroxylation of Hif-1a directly, we again used hydroxyresidue-specific antibodies and studied cells under conditions of MG132-mediated proteasomal blockade to stabilize all forms of Hif-1a irrespective of hydroxylation (Fig. 4A) . These studies revealed that both sets of transfectants completely restored HIF-1a prolyl hydroxylation. Finally, to determine the overall effects on the HIF transcriptional activity, we measured expression of the HIF-target gene transcripts, Bnip3, HK2, Slc2a1 and pyruvate dehydrogenase kinase isoenzyme 1 (Pdk1), by RT -PCR (Fig. 4B) . In each case, both FH-V5 and FH-V5DMTS transfections corrected the upregulation of these transcript levels in normoxic Fh12/2 MEFs. These findings indicate that re-expression of extramitochondrial FH is sufficient for complete correction of the normoxic upregulation of the HIF pathway in Fh12/2 cells, irrespective of persistent deficiency in mitochondrial respiration.
DISCUSSION
Taken together, our findings provide clear evidence that upregulation of the HIF pathway in Fh1-deficient cells occurs as a result of inhibition of HIF-1a prolyl hydroxylation by accumulated intracellular fumarate and is independent of the defect in mitochondrial oxidative metabolism (Fig. 5) . Total correction of Hif-1a pathway activation in Fh12/2 MEFs by extra-mitochondrial expression of FH indicates that, at least in this context, neither impaired mitochondrial function itself nor the consequent dependence of energy metabolism on glycolysis contribute importantly to this process. Experiments using hydroxy-residue-specific antibodies revealed that Hif-1a prolyl and asparaginyl hydroxylation were differentially impaired in both Fh1-deficient cells and tumours. These results are in agreement with analyses on recombinant PHDs and FIH, which demonstrate that fumarate is a better inhibitor of the PHDs than FIH in kinetic assays conducted in vitro (11, 12) .
Although both the current and previous studies have consistently demonstrated upregulation of HIF in FH-associated neoplasia (6, 20, 21) , this does not prove that HIF activation is the causative oncogenic pathway in this setting. Recent work has indicated that the human genome encodes as many as 60-70 known or predicted 2-OG-dependent oxygenases (22) . Described functions include prolyl and lysyl hydroxylation of collagen, histone lysyl and arginyl demethylation, lysyl hydroxylation of proteins associated with RNA splicing, different steps in carnitine metabolism, the repair of alkylated bases in DNA, single-and double-stranded nucleic acid To date, no HLRCC mutations that occur in the MTS have been described consistent with the 'tumour suppressor' function of FH being extra-mitochondrial. In this context, it is of interest that recent studies of Saccharomyces cerevisiae have revealed that yeast cells, which have been engineered to be defective in cytosolic, but not mitochondrial fumarase (equivalent to FH), show defective DNA repair responses (24) . Based on these findings, and on the action of exogenous fumarate, it has been proposed that fumarate itself may have a role in DNA repair. Whether these effects are due to an action on a 2-OG oxygenase function is not yet clear. However, the derivation of a mammalian cellular model that enables the effects of fumarate accumulation to be distinguished from those of defective mitochondrial function should now be of considerable use in dissecting the potentially complex effects of FH inactivation on 2-OG oxygenase functions and in defining the oncogenic pathways operating in FH-associated disease. It will also provide a platform for the definition and monitoring of potential therapeutic interventions designed to restrict fumarate accumulation in this setting. Glux 100. Both Fh12/2 and Fh12/2 +FHDMTS MEFs showed a reduced capacity to maintain ATP levels (80 and 60%, respectively), whereas Fh1+/+ and Fh12/2 +FH MEFs showed comparable levels of ATP. Results are shown as mean + SD of triplicate assays. 
MATERIALS AND METHODS

Generation and maintenance of immortalized Fh1-deficient MEFs
Fh1 conditional knockout mice (20) were maintained in accordance with Home Office guidelines and licensing regulations. Fh1 mice were inter-crossed, and MEFs were isolated from littermate embryos and dissected at 14.5 days of gestation using standard protocols. Cells (at passage number 3) were transfected with pBabe-puro SV40 Large T antigen (25) (10 8 PFU) and immortalized cells were selected with puromycin. Excision of the Fh1 loxP-flanked exon was effected by transfection using an adenovirus-type 5 (dE1/E3) vector, with a cytomegalovirus (CMV) promoter-driven Cre recombinase transgene and green fluorescent protein (GFP) tag (Ad-Cre-GFP) (Vector Biolabs). A similar vector lacking the Cre transgene but also driven by the CMV promoter (Ad-CMV-GFP) was used as a control. Transfection efficiency was 80%, as assessed by GFP expression. Clones were established and the genotype was confirmed by PCR of genomic DNA (20) . All MEFs were cultured in Dulbecco's modified Eagle's medium (DMEM; Sigma) containing 4500 g/l glucose supplemented with 10% (v/v) fetal bovine serum (Sigma), 2 mM glutamine (Sigma) and maintained in a humidified atmosphere of 5% CO 2 and 21% O 2 .
Generation of MEFs with stable FH expression
Wild-type human FH with and without the MTS was inserted into pEF1/V5-His (Invitrogen) using PCR (details on request). Fh12/2 MEFs were transfected using FuGene w 6 Transfection Reagent (Roche), according to the manufacturer's instructions. Post-transfection (72 h), cells were placed under G418 selection. Surviving cells were then analysed by immunofluorescence to confirm appropriate sub-cellular localization. Independent clones were isolated from these heterogeneous populations of transfected cells, and expression and localization were re-confirmed.
Human and murine tissues and cell lines
The frozen FH-mutant type II papillary renal cancer, VHL-mutant clear cell renal cancer and FH-deficient cells were collected with full ethical approval in collaboration with Professor Ian Tomlinson (Oxfordshire REC B 05/Q1605/66 'Molecular analyses of archival tumours'). Fh1-and Vhldeficient mice have been previously described (20, 26) .
Immunoblotting and antibodies
Whole-cell extracts and immunoblot analysis were carried out as described previously (6) . The following primary antibodies were used: HIF-1a (Novus), Hydroxy-HIF-1a (Pro564; Cell Signalling Technology, no. 3434), Hydroxy-HIF-1a (Pro402; Millipore, no. 07-1585), Hydroxy-HIF-1a (Asn803) (27) , b-actin-HRP (Abcam) and FH (Autogen Bioclear).
Immunofluorescence and confocal analysis
Prior to fixation, cells were labelled with 250 nM Mitotracker w Red CMXRos (Invitrogen). Cells were fixed in 10% neutral buffered formalin (Sigma), with an additional fixation in methanol (Sigma) at 2208C, and permeabilized with 0.025% Triton X-100 (Sigma). V5-tagged FH protein was visualized with anti-V5-FITC-conjugated antibody (Invitrogen). Cells were mounted in Vectashield w with DAPI 4',6-diamidino-2-phenylindolel (Vector Labs). Pictures were acquired using the Zeiss LSM510 MetaHead confocal microscope and using LSM 510 software v4.2 (Carl Zeiss GmbH). Immunoblotting using hydroxy-residue-specific antibodies confirmed that Fh12/2 MEFs transfected with either FH-V5 or FH-V5DMTS restored Hif-1a hydroxylation at the Pro402 and Pro577 residues. Neither FH-V5 nor FH-V5DMTS transfection affected hydroxylation at Asn813. qRT-PCR analysis of Hif-1a target genes shows that mRNA levels in both Fh12/2 +FH and Fh12/2 +FHDMTS MEFs are reduced to a similar range to levels observed in Fh1+/+ MEFs. Results are shown relative to the mRNA levels in Fh12/2 cells; mean + SD of triplicate assays.
Measurement of FH activity
Determination of enzymatic activity of FH was performed as described previously (28) .
MRS metabolite analysis
MRS was performed as described previously (6) . In brief, metabolites were extracted from cells, using perchloric acid, and freeze-dried. The samples were resuspended in D 2 O and analysed using 1 H MRS. Cell culture media were also collected and analysed by 1 H MRS. Sodium 3-trimethylsilyl-2,2,3,3-tetradeuterpropionate (TSP) was added to the samples for chemical shift calibration and quantification.
Quantitative reverse transcription -PCR
qRT -PCR for quantification of mRNA employed Taqman gene expression assays on a StepOne thermocycler (Applied Biosystems). Total RNA was extracted using Tri-reagent (Sigma) according to the manufacturer's protocol. Singlestrand cDNA synthesis was generated from 2 mg of total RNA (Applied Biosystems). Normalization was to b-actin mRNA and relative gene expression was calculated using the DDCT method. Fifty nanograms of cDNA template per reaction were used and three biological replicates, each in triplicate, were performed for each experiment.
Measurement of mitochondrial respiration
MEFs (2 × 10 6 cells) were harvested and washed in 100 mM KCl, 50 mM MOPS and 0.5 mM EGTA to remove any cell culture media. Cells were resuspended in respiratory media (100 mM KCl, 50 mM MOPS, 1 mM EGTA, 5 mM KH 2 PO4 and 1 mg/ml BSA, pH 7.4) and transferred to a Clark-type oxygen electrode (Strathkelvin, UK) at 308C for the measurement of mitochondrial respiration (29) . Respiration was measured under basal unstimulated conditions, following the addition of glutamate (20 mM), the ATP synthase inhibitor oligomycin (2 mM) and the metabolic uncoupler (FCCP; 10 mM).
ATP measurements
Levels of ATP were determined using a CellTiter-Glo w Assay (Promega, Madison) on white 96-well plates (Greiner Bio One, Frickenhausen, Germany) according to the manufacturer's instructions. Briefly, cells were plated at a density of 5 × 10 4 cells per well in 96-well plates and grown in DMEM supplemented with either 25 mM glucose or 25 mM galactose. Cells grown in each condition were lysed simultaneously at 0, 2, 4 and 6 h and luminescent signals measured using a plate reader (Victor 2; PerkinElmer Life Sciences). 
Statistical analysis
Statistical comparisons for qRT-PCR were performed using the Student's unpaired t-test. Data on mitochondrial respiration were analysed using one-way ANOVA and Tukey's post hoc analysis.
